Levonic

Levofloxacin, the active ingredient in Levonic, is a fluoroquinolone presented as an intravenous solution for IV use. It treats a range of serious bacterial infections in adult patients, including community‑acquired pneumonia, complicated urinary tract infections, skin and soft tissue infections, intra‑abdominal infections, and bacterial sinusitis.

GNH USA supplies Levonic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring quality and regulatory compliance across global markets, with a focus on timely delivery, cold‑chain logistics where required, and comprehensive documentation for import and distribution.

Levofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections in various organ systems.

- Community‑acquired pneumonia: effective bacterial eradication leading to clinical recovery. - Complicated urinary tract infections: eradicates resistant uropathogens and resolves infection. - Skin and soft tissue infections: clears bacterial involvement and promotes wound healing. - Intra‑abdominal infections: eliminates polymicrobial infection sources. - Bacterial sinusitis: resolves sinus inflammation caused by susceptible bacteria.

Levofloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, requiring immediate medical attention. - QT interval prolongation: may precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Hepatic toxicity: elevated liver enzymes or jaundice.

Levofloxacin requires careful consideration of patient‑specific factors.

- Renal impairment: dose adjustment may be required to avoid accumulation. - History of tendon disorders: avoid use due to increased risk of tendon rupture. - QT prolongation risk: monitor ECG in patients with cardiac history. - Pregnancy Category C: use only if potential benefits justify potential fetal risks. - Concomitant drugs: assess for interactions that may increase toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levofloxacin can interact with several medicines, altering safety or efficacy.

Major Interactions (Avoid): - NSAIDs: co‑administration may increase risk of central nervous system toxicity. - QT‑prolonging agents (e.g., quinidine, macrolides): may cause serious arrhythmias. - Systemic corticosteroids: combined use raises tendon rupture risk.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may reduce levofloxacin absorption. - Warfarin: concurrent use can enhance anticoagulant effect, requiring INR monitoring. - Theophylline: levofloxacin may increase theophylline plasma levels, necessitating dose adjustment.